cytomegalovirus phosphoprotein 65 derived peptide vaccine

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namecytomegalovirus phosphoprotein 65 derived peptide vaccine
Drug Alias NameCMVpp65 (University Heidelberg)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHeidelberg University
China Registration ClassN/A

Develop Information

Active CompaniesHeidelberg University
Inactive CompaniesN/A
Active IndicationsCytomegalovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A